Literature DB >> 11415908

Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis.

A Bizzi1, A M Uluğ, T O Crawford, T Passe, M Bugiani, R N Bryan, P B Barker.   

Abstract

Serial MR imaging and quantitative proton MR spectroscopic imaging (MRSI) findings of a 4-year-old boy with acute disseminated encephalomyelitis (ADEM) are reported. Over a 2-month period characterized by an initial illness and two relapses, each with full recovery, MR imaging exhibited the appearance and disappearance of multifocal lesions throughout the CNS that correlated only partly with the neurologic impairment. During one relapse, MRSI revealed low levels of N-acetylaspartate (NAA) within the regions of prolonged T2 signal intensity. All other metabolites were normal. At follow-up, the MR imaging and MRSI abnormalities had fully resolved. MRSI might play an important role in the diagnosis of ADEM, as well as in the elucidation of underlying pathophysiologic processes in this poorly defined disorder of children. This case demonstrates that reduced levels of NAA are not always associated with neuronal loss, irreversible tissue damage, or poor neurologic outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11415908      PMCID: PMC7974787     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  19 in total

1.  Quantitative proton MR spectroscopic imaging of the human brain.

Authors:  B J Soher; P C van Zijl; J H Duyn; P B Barker
Journal:  Magn Reson Med       Date:  1996-03       Impact factor: 4.668

2.  Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo.

Authors:  T E Bates; M Strangward; J Keelan; G P Davey; P M Munro; J B Clark
Journal:  Neuroreport       Date:  1996-05-31       Impact factor: 1.837

3.  Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis.

Authors:  J Kesselring; D H Miller; S A Robb; B E Kendall; I F Moseley; D Kingsley; E P du Boulay; W I McDonald
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

4.  In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo.

Authors:  K K Bhakoo; D Pearce
Journal:  J Neurochem       Date:  2000-01       Impact factor: 5.372

5.  Normalization of contralateral metabolic function following temporal lobectomy demonstrated by 1H magnetic resonance spectroscopic imaging.

Authors:  J W Hugg; R I Kuzniecky; F G Gilliam; R B Morawetz; R E Fraught; H P Hetherington
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

6.  Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy.

Authors:  J Vion-Dury; F Nicoli; A M Salvan; S Confort-Gouny; C Dhiver; P J Cozzone
Journal:  Lancet       Date:  1995-01-07       Impact factor: 79.321

7.  Mast cells contain large quantities of secretagogue-sensitive N-acetylaspartate.

Authors:  A P Burlina; V Ferrari; L Facci; S D Skaper; A B Burlina
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

8.  Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

Authors:  C A Davie; C P Hawkins; G J Barker; A Brennan; P S Tofts; D H Miller; W I McDonald
Journal:  Brain       Date:  1994-02       Impact factor: 13.501

9.  Proton NMR spectroscopy of Canavan's disease.

Authors:  P B Barker; R N Bryan; A J Kumar; S Naidu
Journal:  Neuropediatrics       Date:  1992-10       Impact factor: 1.947

10.  Multisection proton MR spectroscopic imaging of the brain.

Authors:  J H Duyn; J Gillen; G Sobering; P C van Zijl; C T Moonen
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

View more
  19 in total

Review 1.  Acute disseminated encephalomyelitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

2.  [Value of MR spectroscopy in infectious and inflammatory brain diseases].

Authors:  P Papanagiotou; K I Schmidt; M Alexandrou; H Körner; W Reith
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

3.  Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis.

Authors:  K S Balasubramanya; J M E Kovoor; P N Jayakumar; S Ravishankar; R B Kamble; J Panicker; D Nagaraja
Journal:  Neuroradiology       Date:  2006-11-28       Impact factor: 2.804

Review 4.  [Magnetic resonance spectroscopy for inflammatory brain diseases].

Authors:  P Papanagiotou; I Q Grunwald; G Farmakis; K M Hartmann; M Politi; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

Review 5.  [Acute disseminated encephalomyelitis].

Authors:  M Politi; P Papanagiotou; I Q Grunwald; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

Review 6.  MR spectroscopy in children: protocols and pitfalls in non-tumorous brain pathology.

Authors:  Jacques F Schneider
Journal:  Pediatr Radiol       Date:  2016-05-27

7.  Proton magnetic resonance spectroscopy in childhood brainstem lesions.

Authors:  L Porto; E Hattingen; U Pilatus; M Kieslich; B Yan; D Schwabe; F E Zanella; H Lanfermann
Journal:  Childs Nerv Syst       Date:  2006-09-16       Impact factor: 1.475

8.  Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications.

Authors:  Ashok Panigrahy; Marvin D Nelson; Stefan Blüml
Journal:  Pediatr Radiol       Date:  2009-11-24

9.  An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children.

Authors:  Matthew VanLandingham; William Hanigan; Vetta Vedanarayanan; Jonathan Fratkin
Journal:  Childs Nerv Syst       Date:  2009-12-01       Impact factor: 1.475

10.  1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage.

Authors:  Liat Ben Sira; Elka Miller; Moran Artzi; Aviva Fattal-Valevski; Shlomi Constantini; Dafna Ben Bashat
Journal:  Pediatr Radiol       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.